Amitiza (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Amitiza drug offered from Takeda Pharmaceuticals America, Inc.. This Chloride Channel Activator [EPC],Chloride Channel Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | lubiprostone |
| SUBSTANCE NAME: | LUBIPROSTONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Chloride Channel Activator [EPC],Chloride Channel Activators [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-01-31 |
| END MARKETING DATE: | 0000-00-00 |
Amitiza HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amitiza from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8(ug/1) |
| START MARKETING DATE: | 2006-01-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-080_25bf735c-04fe-4067-8108-21956899b68b |
| PRODUCT NDC: | 64764-080 |
| APPLICATION NUMBER: | NDA021908 |
Other LUBIPROSTONE Pharmaceutical Manufacturers / Labelers:
